Microsoft: A Critical Point in Valuation Momentum
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
Exelixis (EXEL) stock forecast for 2025
Updated: May 22, 2025 (18:22)
Sector: HealthcareThe share price of Exelixis, Inc. (EXEL) now
50/200 Day Moving Average: $37.64 / $33.06
This figure corresponds to the Average Price over the previous 50/200 days. For Exelixis stocks, the 50-day moving average is the resistance level today.
For Exelixis stocks, the 200-day moving average is the resistance level today.
Are you interested in Exelixis, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Exelixis stock price in 2025. How much will one Exelixis share be worth in 2025? Is it worth taking profit / loss on EXEL stock now or waiting? What are analysts' forecasts for Exelixis stock?
We forecast Exelixis stock performance using neural networks based on historical data on EXEL stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Exelixis, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Exelixis analysts is $40.78. Today 200 Day Moving Average is the support level (33.06 $). 50 Day Moving Average is the support level (37.64 $).
Historical and forecast chart of Exelixis, Inc. stock
The chart below shows the historical price of Exelixis stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the EXEL stock price can be found in the table below.
Exelixis, Inc. is a biotechnology company specializing in the development of promising low molecular weight drugs for the treatment of cancer and other serious diseases, including kidney damage, thyroid cancer and progressive melanoma. In addition, the company is forging strategic partnerships with other pharmaceutical and biotech companies.
Exelixis (EXEL) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun | 46.44 | 44.35 | 47.44 | 6.52 % |
| Jul | 50.61 | 48.61 | 53.94 | 9.88 % |
| Aug | 52.21 | 50.56 | 55.92 | 9.58 % |
| Sep | 50.28 | 48.20 | 52.82 | 8.74 % |
| Oct | 48.52 | 46.03 | 50.57 | 8.98 % |
| Nov | 46.73 | 45.04 | 49.75 | 9.47 % |
| Dec | 48.96 | 46.93 | 51.34 | 8.58 % |
Exelixis information and performance
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, US
Market capitalization of the Exelixis, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of EXEL shares in the company outstanding by the market price of one share.
EBITDA of Exelixis is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Exelixis price target for 2025 by month
Target values for the price of one Exelixis share for Jun 2025.
In Jun, the Positive dynamics for Exelixis, Inc. shares will prevail with possible monthly volatility of 6.519% volatility is expected.
Pessimistic target level: 44.35
Optimistic target level: 47.44
Target values for the price of one Exelixis share for Jul 2025.
In Jul, the Positive dynamics for Exelixis, Inc. shares will prevail with possible monthly volatility of 9.881% volatility is expected.
Pessimistic target level: 48.61
Optimistic target level: 53.94
Target values for the price of one Exelixis share for Aug 2025.
In Aug, the Positive dynamics for Exelixis, Inc. shares will prevail with possible monthly volatility of 9.579% volatility is expected.
Pessimistic target level: 50.56
Optimistic target level: 55.92
Target values for the price of one Exelixis share for Sep 2025.
In Sep, the Negative dynamics for Exelixis, Inc. shares will prevail with possible monthly volatility of 8.740% volatility is expected.
Pessimistic target level: 48.20
Optimistic target level: 52.82
Target values for the price of one Exelixis share for Oct 2025.
In Oct, the Negative dynamics for Exelixis, Inc. shares will prevail with possible monthly volatility of 8.980% volatility is expected.
Pessimistic target level: 46.03
Optimistic target level: 50.57
Target values for the price of one Exelixis share for Nov 2025.
In Nov, the Negative dynamics for Exelixis, Inc. shares will prevail with possible monthly volatility of 9.466% volatility is expected.
Pessimistic target level: 45.04
Optimistic target level: 49.75
Target values for the price of one Exelixis share for Dec 2025.
In Dec, the Positive dynamics for Exelixis, Inc. shares will prevail with possible monthly volatility of 8.583% volatility is expected.
Pessimistic target level: 46.93
Optimistic target level: 51.34
Related stocks from Healthcare sector
